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POINT-OF-CARE	ECHOCARDIOGRAPHY	AND	ELECTROCARDIOGRAPHY	IN	ASSESSING	SUSPECTED	PULMONARY	EMBLOSIM.	John	Grotberg,	James	Daley,	Richard	A.	Taylor,	Chris	L.	Moore.	Section	of	Ultrasound,	Department	of	Emergency	Medicine,	Yale	University,	School	of	Medicine,	New	Haven,	CT.		 Daniels	 and	 TwiST	 electrocardiogram	 (ECG)	 scores	 have	 been	 proposed	 to	detect	right	heart	strain	(RHS).	Tricuspid	Annular	Plane	Systolic	Excursion	(TAPSE)	is	 a	 reliable	 indicator	 of	 RHS	 in	 patients	 with	 acute	 pulmonary	 embolism	 (PE).	 I	aimed	 to	 investigate	 the	 relationship	 between	 these	 ECG	 scores,	 TAPSE,	 and	 the	level	 of	 care	 required	 for	 patients	 with	 acute	 PE.	 This	 was	 a	 prospective	observational	 study	of	 110	patients	 undergoing	CTA	 for	 suspected	PE.	 ECGs	were	obtained	 and	 patients	 underwent	 bedside	 echocardiography.	 Low	 TAPSE	 was	defined	as	≤17	mm.	Mean	Daniels	and	TwiST	scores	were	compared	to	mean	TAPSE,	and	 all	 were	 used	 to	 evaluate	 the	 risk	 of	 requiring	 “PE	 elevated	 care”	 (PEEC),	defined	as	care	more	aggressive	than	simple	heparination.	Mean	Daniels	and	TwiST	scores	were	significantly	different	between	low	and	high	TAPSE	groups	(p<0.0001),	and	high	Daniels	and	TwiST	scores	correlated	to	low	TAPSE	(p<0.0001,	p=0.0002).	PE	positive	(PE+)	patients	had	 lower	mean	TAPSE	than	PE	negative	(PE-)	patients	(p=0.0003).	PE+	patients	had	a	higher	mean	Daniels	 score	and	mean	TwiST	score	than	PE-	 patients	 (p=0.0024,	 p=0.0033).	 Patients	 requiring	PEEC	had	 lower	mean	TAPSE	 (p=0.047)	 and	 higher	 mean	 TwiST	 (p=0.020)	 values.	 TAPSE	 ≤17	mm	 and	TwiST	≥5	had	 increased	 risks	 of	 6.9	 (p=0.045)	 and	4.4	 (p=0.025)	 respectively	 for	requiring	PEEC.	Both	the	Daniels	and	TwiST	ECG	scores	correlated	with	TAPSE.	All	three	 were	 predictive	 of	 PE	 on	 CTA,	 while	 TAPSE	 and	 TwiST	 were	 predictive	 of	requiring	PEEC,	suggesting	their	prognostic	value	in	PE	care.		
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1.	Introduction	
1.1	Deep	Venous	Thrombosis	and	Pulmonary	Embolism	
1.1.1	Background	Venous	 thromboembolism	 (VTE),	 encompassing	 both	 deep	 venous	 thrombosis	(DVT)	 and	 pulmonary	 embolism	 (PE),	 is	 one	 of	 the	 three	 leading	 cardiovascular	causes	of	death,	with	the	other	two	leading	causes	being	myocardial	infarction	(MI)	and	 stroke.	 It	 is	 estimated	 that	between	100,000	and	300,000	VTE-related	deaths	occur	annually	in	the	United	States.	Approximately	75%	of	symptomatic	VTE	events	are	 community-acquired,	while	 the	 remaining	 25%	 are	 hospital	 acquired,	making	the	 recognition	 and	 treatment	 of	 VTE	 essential	 in	 both	 emergency	 medicine	 and	critical	 care	 settings	 (1).	 In	 1999,	 the	 International	 Cooperative	 Pulmonary	Embolism	 Registry	 (ICOPER)	 examined	 2454	 consecutive	 eligible	 patients	 with	acute	PE	 from	52	hospitals	 in	7	countries,	analyzing	all-cause	mortalities	within	3	months	of	diagnosis.	The	overall	crude	3-month	mortality	rate	was	17.4%,	of	which	45.1%	were	ascribed	to	PE.	In	addition,	significant	prognostic	 factors	 included	age	over	 70	 years	 old,	 cancer,	 congestive	 heart	 failure	 (CHF),	 chronic	 obstructive	pulmonary	 disease	 (COPD),	 systolic	 arterial	 hypotension,	 tachypnea,	 and	 right	ventricular	 (RV)	hypokinesis	on	echocardiography	 (2).	Due	 to	 the	variety	of	ways	patients	 can	 present	 with	 acute	 PE,	 and	 its	 often,	 deadly	 prognosis,	 it	 is	 often	referred	to	as	a	great	masquerader.	 It	 is	 for	this	reason	that	so	much	research	has	focused	on	understanding	the	pathophysiology,	attaining	better	diagnostic	inclusion	and	exclusion	criteria,	and	determining	prognostic	factors	for	risk	stratification	and	
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therapy.	 The	 bedrock	 of	 research	 in	 diagnosing	 acute	 pulmonary	 embolism	surrounds	 methods	 to	 increase	 the	 sensitivity	 of	 diagnostic	 criteria,	 while	 also	avoiding	unnecessary	radiation	with	CT	scans,	while	also	incorporating	methods	to	properly	stratify	patients	who	may	have	increased	morbidity	and	mortality.		
1.1.2	Pathophysiology		 Acute	PE	has	physiological	consequences	of	interfering	with	both	circulation	and	 gas	 exchange.	 Gas	 exchange	 is	 disrupted	 due	 to	 inflammatory	 mediators,	resulting	 in	 surfactant	dysfunction,	 atelectasis	 and	 intrapulmonary	 shunting	 along	with	 increased	 dead	 space	 ventilation	 and	 V/Q	mismatch	 (3,4),	 while	 circulatory	changes	 occur	 due	 to	mechanical	 obstruction	 from	 the	 thrombus	 (or	 thrombi),	 as	well	 as	 PE-induced	 vasoconstriction	 from	 inflammatory	 mediators	 and	 hypoxia,	leading	to	increased	pulmonary	arterial	pressures	and	vascular	resistance	(4).	Acute	increases	 in	 pulmonary	 vascular	 resistance	 cause	 strain	 on	 the	 right	 side	 of	 the	heart	secondary	to	the	increased	pressure	required	to	maintain	right-sided	cardiac	output.	 Increased	pressures	 in	 the	RV	and	 right	atrium	 leading	 to	RV	dilation	and	systolic	dysfunction	of	the	myocardium.	As	RV	contraction	time	becomes	prolonged,	bowing	of	the	interventricular	septum	can	result	(5),	leading	to	decreased	LV	filling	and	decreased	cardiac	output	and	cardiac	index	(CI).	Additionally,	development	of	a	right	bundle	branch	block	(RBBB)	can	occur	secondary	to	increased	pressure	on	the	subendocardial	 conduction	 system	 as	 well	 as	 decreased	 right	 coronary	 perfusion	pressure.	 This	 can	 exacerbate	 the	 desynchronization	 of	 the	 ventricles,	 leading	 to	decreased	LV	filling	and	hypotension	(6).	An	increase	in	demand	can	also	lead	to	RV	ischemia	 (4).	 The	 aforementioned	 pathophysiology	 can	 result	 in	 a	 fatal	 feedback	
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loop	of	increased	RV	pressure	and	RV	dilation,	decreased	cardiac	output,	decreased	coronary	 perfusion	 pressure	 and	 increased	 RV	 myocardial	 ischemia,	 leading	 to	acute	RV	failure.		
1.1.3	Diagnostic	Evaluation		 In	analyzing	the	current	standards	for	diagnostic	evaluation	of	patients	with	suspected	 PE,	 it	 is	 necessary	 to	 begin	 with	 the	 history	 and	 physical	 exam.	 Even	before	any	serologic	testing	or	 imaging,	patients	can	be	risk	stratified	for	acute	PE	with	PE	Rule-Out	Criteria	(PERC).	In	particular,	PERC	coupled	with	physician	gestalt	for	PE	has	shown	to	be	a	highly	sensitive	test.	The	components	of	the	PERC	criteria	involve	the	following	eight	questions	(7):		1. Is	the	patient	older	than	49	years	of	age?	2. Is	the	pulse	rate	above	99	beats	per	minute?	3. Is	the	pulse	oximetry	reading	>	95%	while	the	patient	breathes	room	air?	4. Is	there	a	present	history	of	hemoptysis?	5. Is	the	patient	taking	exogenous	estrogen?	6. Does	the	patient	have	a	prior	diagnosis	of	venous	thromboembolism	(VTE)?	7. Has	 the	 patient	 had	 recent	 surgery	 or	 trauma	 (Requiring	 endotracheal	intubation	or	hospitalization	in	the	previous	4	weeks)?	8. Does	the	patient	have	unilateral	leg	swelling?		In	 2008,	 a	 large	 study	 incorporating	 more	 than	 8,000	 patients	 across	 13	emergency	departments	evaluated	PERC.	Among	low	gestalt	suspicion	and	PERC	(-)	(answering	no	to	the	8	PERC	questions),	15	patients	were	VTE	(+)	and	one	patient	died,	 yielding	 a	 false	 negative	 rate	 of	 1%.	 As	 a	 diagnostic	 test,	 low	 suspicion	 and	PERC	(-)	had	a	sensitivity	of	97.4%	and	a	specificity	of	21.9%	(8),	allowing	exclusion	of	 PE	 without	 D-dimer	 testing	 that	 could	 lead	 to	 unnecessary	 imaging.	 Avoiding	unnecessary	imaging	and	radiation	is	an	endeavor	that	has	been	investigated,	and	is	one	that	point	of	care	ultrasound	can	also	play	a	role	in	risk	stratification.	In	2012,	
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the	 National	 Quality	 Forum	 (NQF)	 endorsed	 a	 performance	 measure	 to	 increase	imaging	 efficiency	 for	 evaluation	 of	 PE	 in	 the	 ED.	 The	 primary	 outcome	 was	 the	proportion	of	imaging	that	was	potentially	avoidable	according	to	the	NQF	measure,	as	defined	by	imaging	a	patient	with	low	pretest	probability	for	PE	who	either	did	not	have	a	D-dimer	test	ordered,	or	who	had	a	negative	D-dimer	test	result.	It	was	found	that	one	third	of	 imaging	could	be	categorized	as	avoidable	(9).	 	Apart	 from	PERC,	 additional	 criteria	may	 include	presence	of	 limb,	whole-body,	or	neurologic	immobility.	 Contrary	 to	 belief,	 travel	 greater	 than	 8	 hours	 was	 not	 shown	 to	significantly	 increase	 the	 risk	 for	 VTE	 (10).	 It	 should	 be	 noted	 that	 other	 scoring	systems	exist	 to	aid	physicians	 in	gestalt	 for	suspecting	PE.	Notably,	 the	 two	most	commonly	 used	 scoring	 systems	 are	 the	Wells	 PE	 Criteria,	 as	well	 as	 the	 Geneva	Score	(1).	Both	scoring	systems	aid	in	risk	stratifying	patients	and	guiding	the	need	for	further	diagnostic	work	up.	They	overlap	in	many	respects,	including	aspects	of	patient	 history	 such	 as	 age,	 history	 of	 prior	 DVT/PE,	 recent	 surgery	 and	 active	malignancy	(1).	While	the	use	of	ECG	and	bedside	echo	will	be	discussed	further	as	diagnostic	and	prognostic	tools	in	patients	with	suspected	PE,	it	is	also	worth	briefly	discussing	the	value	of	laboratory	tests.	Many	laboratory	tests	also	aid	in	the	diagnostic	work	up	of	patients	with	suspected	PE,	and	include	troponin,	B-type	natriuretic	peptide,	and	D-Dimer	(11).	However,	these	tests	alone	can	be	elevated	in	other	pathologies,	and	must	 therefore	 be	 added	 to	 the	 entirety	 of	 the	 clinical	 context	 surrounding	 a	patient.	 For	 example,	 Kabrhel	 et	 al.	 found	 that	 significant	 positive	 predictors	 of	elevated	D-Dimer	 in	patients	evaluated	 for	PE	 included	 female	sex,	 increasing	age,	
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black	 (vs.	 white)	 race,	 cocaine	 use,	 neurologic	 immobility,	 prior	 venous	thromboembolism,	 hemoptysis,	 hemodialysis,	 active	 malignancy,	 and	 numerous	others.	On	the	other	hand,	several	variables	known	to	be	associated	with	PE	were	not	 significantly	 associated	 with	 a	 positive	 D-Dimer,	 such	 as	 BMI,	 exogenous	estrogen	use,	thrombophilia,	trauma	within	4	weeks,	and	others	(12).		
1.2	Management	of	Acute	Pulmonary	Embolism	
1.2.1	Prevention		 Naturally	 preventing	PE	 is	 an	 important	 endeavor.	 It	 is	 critical	 in	 reducing	the	 death	 rate,	 morbidity,	 and	 financial	 cost	 of	 PE.	 Mechanical	 measures	 and	pharmacological	 measures	 currently	 exist	 to	 aid	 in	 its	 prevention.	 Mechanical	measures	 include	 compression	 stockings,	 intermittent	 pneumatic	 compression	devices	and	placement	of	 temporary	or	permanent	 inferior	vena	cava	(IVC)	 filters.	Pharmacological	 measures	 include	 fractionated	 heparin,	 low-molecular-weight	heparin,	warfarin,	and	fondaparinux	(11).		
1.2.2	Anticoagulation	vs.	Thrombolysis		 When	 discussing	 management	 of	 acute	 PE,	 it	 should	 be	 mentioned	 that	 3	subtypes	exist	that	depend	on	certain	clinical	and/or	diagnostic	criteria.	Massive	PE	is	defined	as	PE	with	sustained	hypotension	(systolic	blood	pressure	<	90	for	more	than	15	minutes)	not	due	to	another	cause	other	than	the	PE	(1).	Submassive	PE	is	defined	 as	 PE	 without	 hypotension,	 but	 with	 evidence	 of	 RV	 dysfunction	 or	myocardial	 necrosis.	 This	 can	 be	 evidenced	 by	 RV	 dilation	 or	 dysfunction	 by	echocardiography,	CT,	elevated	troponin,	elevated	BNP,	or	ECG	changes	consistent	with	 right	 heart	 strain	 (1).	 Low	 risk	 PE	 refers	 to	 those	 PEs	 that	 do	 not	 produce	
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hypotension	or	evidence	of	right	heart	strain	(1).	In	low	risk	and	submassive	PE,	the	common	treatment	is	heparin-based	anticoagulation	by	continuous	infusion	with	a	target	 partial	 thromboplastin	 time	 of	 60-80	 seconds,	 however	 it	 is	 also	 becoming	common	 for	 these	patients	 to	 be	 treated	with	Novel	Oral	Anticoagulants	 (NOACs)	such	as	rivaroxaban	and	apixaban,	or	bivalirudin	for	patients	with	heparin-induced	thrombocytopenia	(HIT),	while	patients	with	massive	PE	often	receive	thrombolysis	by	recombinant	tissue	plasminogen	activator	(tPA)	as	100	mg	continuously	infused	over	 a	 2	 hour	 period	 (11).	 However,	 controversy	 remains	 about	 how	 to	 treat	patients	 with	 submassive	 PE	 who	 are	 normotensive.	 In	 a	 double-blinded	 study	conducted	in	49	centers	in	Germany	by	the	Management	Strategies	and	Prognosis	of	Pulmonary	 Embolism	 Trial-3	 (MAPPET-3),	 normotensive	 patients	 with	 acute	 PE	were	 randomly	 treated	 with	 tPA	 (after	 excluding	 bleeding	 risk)	 and	 heparin	 or	placebo	 and	 heparin.	 The	 primary	 endpoint	 examined	 included	 death	 or	 clinical	deterioration.	 The	 incidence	 of	 primary	 endpoint	 was	 significantly	 higher	 in	 the	placebo	and	heparin	group	compared	to	tPA	and	heparin	and	the	probability	of	30-day	event	free	survival	was	significantly	higher	in	the	tPA	and	heparin	group	(13).	This	 data	 echoed	 earlier	 data	 from	 Goldhaber	 et	 al.	 (14),	 and	 has	 since	 been	discussed	 in	case	reports	 (15,16),	 in	which	patients	who	received	 tPA	had	a	more	rapid	reversal	of	RV	dysfunction,	and	experienced	no	recurrence	of	clinical	episodes	of	PE	compared	to	5	recurrences	and	2	deaths	in	the	heparin-alone	group.				 The	rapid	improvement	and	lower	incidence	of	adverse	clinical	outcomes	of	patients	who	received	tPA	raises	the	importance	of	acquiring	new	methods	of	risk	stratification	 for	 emergency	 department	 physicians.	 Identifying	 the	 subset	 of	
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patients	 with	 submassive	 PE	 and	 prognostic	 indication	 for	 poor	 clinical	 outcome	may	 aid	 in	 driving	 therapy	 with	 tPA	 if	 they	 are	 low	 risk	 for	 bleeding.	 While	continued	research	must	be	performed	in	the	risk	for	bleeding	of	patients	with	acute	PE,	 a	 study	of	 104	patients	 at	Brigham	and	Women’s	Hospital	with	 acute	PE	who	received	 tPA	was	performed,	 and	major	 bleeding	was	 found	 in	19.2%	of	 patients.	The	 principal	 site	 of	 bleeding	was	 unknown	 (45%),	while	 other	 sites	 included	GI,	retroperitoneal,	 splenic,	 and	 intracranial	 (5%).	 It	 was	 also	 determined	 that	independent	predictors	 for	major	bleeding	were	administration	of	 catecholamines	for	 systemic	 arterial	 hypotension,	 cancer,	 diabetes	 mellitus,	 and	 elevated	international	normalized	ratio	(INR)	prior	to	fibrinolysis	(17).	These	relatively	high	rates	of	spontaneous	bleeding	may	have	occurred	due	to	many	factors,	namely	the	increased	average	 INR	 in	patients	who	had	high	risk	bleeding	events	compared	 to	those	who	did	not	(1.4	vs	1.1),	as	well	as	the	small	sample	size	(only	1	patient	had	an	intracranial	hemorrhage,	which	represented	5%	of	the	patients	who	had	a	major	bleeding	event)	(17).	More	recent	literature	has	evaluated	whether	the	dose	of	100	mg	tPA	as	a	continuous	infusion	may	be	increasing	the	bleeding	risk,	and	has	sought	to	elucidate	whether	lower	doses	of	tPA	can	both	improve	RV	function	and	mortality	while	 also	 minimizing	 the	 risk	 of	 spontaneous	 hemorrhage	 in	 patients	 with	submassive	PE.		A	meta-analysis	by	Zhang	et	al.	showed	that	decreased	doses	of	tPA	(0.6	mg/kg	bolus	followed	by	50	mg/2h)	in	patients	with	acute	PE	was	non-inferior	in	achieving	hemodynamic	improvement	when	compared	to	standard	doses	of	tPA	(100	mg),	while	also	yielding	a	decreased	bleeding	risk	compared	to	standard	tPA	
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dosing,	as	well	as	showing	no	increased	risk	in	bleeding	when	compared	to	heparin	alone	(18).		
1.2.3	Invasive	Therapies	for	Acute	Pulmonary	Embolism		 It	 should	be	noted	 that	 for	patients	with	contraindications	 to	 thrombolysis,	catheter-based	 or	 surgical	 embolectomy	 can	 be	 considered	 if	 risk	 stratification	indicates	 a	 high	 probability	 of	 poor	 outcome	 leading	 to	 loss	 of	 hemodynamic	stability	 (11).	 The	 prognosis	 for	 open	 embolectomy	 has	 dramatically	 improved.	During	its	renaissance,	newer	surgical	techniques	led	to	an	89%	survival	rate	of	29	embolectomies	performed	at	Brigham	and	Women’s	Hospital	within	a	2-year	period	(11).	Other	 invasive	strategies	 include	catheter-mediated	thrombus	fragmentation,	rheolytic	 thrombectomy,	 catheter-mediated	 thromboembolus	 aspiration,	 and	catheter-directed	 thrombolysis	 via	 infusion	 catheters	 such	 as	 the	 Endo	 Wave	System	(EKOS)	(19).	Catheter	directed	thrombolysis	has	been	shown	to	improve	RV	function	 by	 reducing	 pulmonary	 arterial	 pressures	 as	well	 as	 RV	 pressures	while	decreasing	 the	 risk	 of	 adverse	bleeding	when	 compared	 to	 systemic	 thrombolysis	(19).			
1.2.4	Inhaled	Nitric	Oxide		 As	previously	mentioned,	acute	PE	 increases	pulmonary	arterial	 resistance,	and	can	lead	to	right	ventricular	failure	and	circulatory	collapse.	Inhaled	nitric	oxide	(NO)	 leads	 to	 immediate	 vasodilation	 of	 the	 pulmonary	 circulation.	 Inhaled	NO	 is	selective	 to	 the	pulmonary	circulation	due	 to	 its	 rapid	binding	and	 inactivation	by	hemoglobin.	Thus,	systemic	circulation	does	not	experience	vasodilation	(20).	Thus	far,	there	have	been	no	randomized	controlled	trials	evaluating	the	effect	of	inhaled	
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NO	on	patients	with	massive	and	submassive	PE.	However,	numerous	case	studies	have	 shown	 it	 holds	 promise,	 in	 particular	 with	 patients	 for	 which	 tPA	 may	 be	contraindicated	 (20-22).	 For	 example,	 Szold	 et	 al.	 found	 that	 in	 four	 patients	suffering	from	acute	massive	PE	after	having	abdominal	surgery,	inhaled	NO	(20-25	ppm),	 led	an	 improvement	 in	pulmonary	and	systemic	blood	pressures,	heart	rate	and	lung	gas	exchange	within	minutes	after	administration	(20).	
1.3	Tricuspid	Annular	Plane	Systolic	Excursion	(TAPSE)		
1.3.1	Assessment	of	Right	Ventricular	Systolic	Function	
	 There	are	several	direct	and	surrogate	measures	of	right	heart	strain	in	acute	PE,	but	the	quantitative	measurement	of	tricuspid	annular	plane	systolic	excursion	(TAPSE)	has	been	found	to	be	reproducible	and	to	provide	prognostic	value	in	both	PE	 and	 other	 disorders.	 The	 determination	 of	 TAPSE	 by	 bedside	 echo	 in	 the	Emergency	Department	has	been	less	well	investigated.	Due	to	the	limited	access	to	cardiology	consults	at	some	hospitals,	or	due	to	the	amount	of	time	it	may	take	for	a	consult,	early	risk	stratification	by	emergency	physicians	for	patients	with	acute	PE	may	help	guide	appropriate	therapy	and	prognosis.	The	 ability	 to	 assess	 RV	 systolic	 function	 in	 an	 Emergency	 Department	setting	 is	 critical	 in	 aiding	 in	 the	 formulation	 of	 a	 diagnosis	 for	 patients	 with	undifferentiated	dyspnea	or	pleuritic	chest	pain,	as	well	as	for	directing	therapy.	As	previously	mentioned,	the	presence	of	RV	systolic	dysfunction	is	a	major	indication	for	 thrombolytic	 therapy	 and	 a	 prognostic	 indicator	 in	 patients	 with	 massive	 or	submassive	PE	 (23).	 2D	 echocardiography	provides	 a	 unique	 tool	 that	 emergency	physicians	can	use	at	the	bedside	to	assess	RV	function	and	acute	right	heart	strain.	
		
15	
Many	 2D	 echocardiography	 assessments	 of	 RV	 strain,	 and	 more	 specifically	 RV	strain	in	acute	PE,	are	qualitative	in	nature,	and	include	RV	size	compared	to	LV	size,	septal	flattening,	tricuspid	regurgitation	with	color	flow	Doppler,	paradoxical	septal	motion,	 diastolic	 left	 ventricular	 (LV)	 impairment,	 direct	 visualization	 of	 PE,	 right	ventricular	 hypertrophy	 (RVH),	 a	 qualitatively	 plethoric	 inferior	 vena	 cava	 (IVC),	and	 McConnell’s	 sign	 (RV	 free	 wall	 hypokinesis	 with	 apical	 sparing)	 (23-25).	 In	particular,	the	apical	sparing	of	McConnell’s	sign	has	been	explained	by	mechanical	tethering	 of	 the	 RV	 apex	 to	 a	 hyperdynamic	 left	 ventricle	 (24,25).	 However,	cardiologists	have	sought	more	quantitative	measurements	to	estimate	RV	systolic	function,	 many	 of	 which	 have	 not	 permeated	 emergency	 medicine	 research	 and	clinical	practice.		One	such	measurement	is	that	of	tricuspid	annular	plane	systolic	excursion,	or	 TAPSE.	 The	 right	 side	 of	 the	 heart,	 unlike	 the	 left	 side,	 contracts	 along	 the	longitudinal	axis	of	the	heart	due	to	the	longitudinal	direction	of	RV	muscle	fibers.	This	 can	 be	 visualized	 on	 transthoracic	 echocardiogram	 (TTE)	 as	 the	 base	 of	 the	heart	ascends	toward	the	apex	in	a	standard	apical	4-chamber	window.	M-mode	is	then	 used	 along	 the	 plane	 of	 the	 tricuspid	 annulus,	 creating	 a	 waveform	 as	 the	annulus	ascends	during	systole	(23)	(Figure	1).	The	TAPSE	measurement	provides	a	quantitative	 value	 of	 the	 linear	 displacement	 of	 the	 tricuspid	 annulus	 between	systole	 and	 diastole.	 In	 terms	 of	 its	 relation	 to	 RV	 systolic	 function,	 Ghio	 et	 al.	determined	that	TAPSE	can	be	a	physiological	index	of	RV	function	based	on	RVEF	estimates	with	thermal	dilution	and	cross-sectional	areas	methods	(27).	Kaul	et	al.	as	 well	 as	 Ueti	 et	 al.,	 showed	 that	 tricuspid	 annulus	 excursion	 correlated	well	 to	
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right	 ventricular	 ejection	 fraction	 (RVEF),	 confirmed	 by	 radionucleotide	angiography	 (28,29).	 Additionally,	 Ueti	 et	 al.	 showed	 a	 significant	 inverse	correlation	between	mean	pulmonary	arterial	pressure	(MPAP)	and	RVEF,	D	wave	integral	(DWI),	peak	velocity	of	D	wave	(PVDW)	and	TAPSE.	This	was	interpreted	as	the	 well-known	 relation	 between	 pulmonary	 artery	 pressure	 and	 RVEF	 in	pulmonary,	myocardial	and	valvular	heart	disease,	and	results	from	the	dependence	of	 right	 ventricular	 systolic	 function	 on	 afterload	 (29).	 Miller	 et	 al.	 also	 found	 a	correlation	between	TAPSE	and	RVEF,	and	high	specificity	and	negative	predictive	value	 for	 detecting	 abnormal	 RV	 systolic	 function	 (30).	 It	 has	 also	 been	demonstrated	 that	 TAPSE	 correlates	 strongly	 with	 RV	 fractional	 area	 change	(RVFAC),	log	B-type	natriuretic	peptide,	and	pulmonary	vascular	resistance	(PVR).	A	TAPSE	of	17.5	mm	was	determined	to	be	the	best	cutoff	for	detection	of	RV	systolic	dysfunction,	defined	by	RVFAC	<	30%,	with	a	sensitivity	of	87%	and	a	specificity	of	91%	 (23).	 Furthermore,	 its	 correlation	 to	 RVFAC	 has	 been	 proven	 as	 a	 useful	measurement	 for	 RV	 systolic	 function	 regardless	 of	 pulmonary	 artery	 pressures	(31).		 However,	 it	 should	be	noted	 that	 this	still	 remains	an	area	of	contention	 in	the	 literature	 and	 reproducibility	of	 these	 correlations,	 as	Anderson	et	 al.	 showed	little	 correlation	 between	 combining	 TAPSE	 in	M-mode	 and	 tissue	Doppler	 of	 the	tricuspid	 annulus	 (TAPSE-TDI)	 with	 RVEF	 as	 measured	 by	 radionuclide	angiocardiography	 and	 gated	 blood-pool	 single	 photon	 electron	 computed	tomography,	while	fractional	area	change	of	the	RV	and	RV	myocardial	performance	index	by	pulsed-wave	Doppler	and	tissue	Doppler	correlated	well	with	RVEF	(32).	
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Moreover,	 it	has	been	suggested	 that	TAPSE	alone	 is	note	solely	dependent	on	RV	systolic	function,	but	also	on	LV	systolic	function	due	to	tethering	and	translational	motion	of	 the	heart	 (23).	 Lopez-Candales	 et	 al.	 concluded	 that	TAPSE	<	20	mm	 is	associated	with	some	degree	of	either	RV	or	LV	dysfunction,	and	TAPSE	>	20	mm	suggests	normal	biventricular	systolic	function	(33).	Finally,	it	has	also	been	shown	that	TAPSE	does	not	 correlate	well	with	RVEF	 in	patients	with	Tetralogy	of	Fallot	(TOF)	(34).	Thus,	when	evaluating	right	heart	strain,	low	TAPSE	values	must	added	to	the	entirety	of	the	clinical	picture	when	assessing	patients	with	echocardiography	as	it	relates	to	diagnostic	and	prognostic	indications.		Among	 the	 numerous	 conditions	 known	 to	 cause	 right	 heart	 strain,	 TAPSE	has	 been	 used	 to	 evaluate	 congestive	 heart	 failure	 (CHF)	 (27),	 MI	 (35-37),	hypertrophic	 cardiomyopathy	 (38),	 pulmonary	 hypertension	 (39-41),	 post-operatively	 (42),	congenital	heart	procedures	(43),	chronic	obstructive	pulmonary	disease	(COPD)	(44),	and	PE	(23,45-47).		In	addition,	TAPSE	has	been	shown	to	have	prognostic	 value	 in	 many	 of	 these	 conditions,	 including	 risk	 stratification	 and	survival	prediction	in	pulmonary	arterial	hypertension	(PAH)	(41,48),	heart	failure	(25,47),	LV	systolic	dysfunction	(50),	and	ARDS	(51).		
1.3.2	Prognostic	Value	of	RV	Dysfunction	in	Pulmonary	Embolism		 RV	 dysfunction	 is	 often	 evaluated	 by	 echocardiography	 in	 patients	 with	suspected	PE.	It	can	aid	in	particular	in	both	the	diagnostic	workup	and	prognostic	risk	 stratification	 of	 patients	with	 submassive	 PE	 (23,24,45-47,52,53),	 or	massive	PE	 leading	 to	 cardiac	 arrest	 and	 pulseless	 electrical	 activity	 (PEA)	 (54).	 RV	dysfunction	has	been	established	as	a	predictor	of	 increased	likelihood	of	death	or	
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other	adverse	clinical	outcomes	from	pulmonary	embolism	(45-47,55).	Ribeiro	et	al.	examined	 126	 consecutive	 PE-positive	 patients	 with	 2D	 echocardiography.	 They	divided	patients	into	two	groups:	those	with	normal	or	slightly	reduced	RV	function,	and	 those	 with	 moderately	 or	 severely	 reduced	 RV	 function.	 RV	 dysfuction	 was	determined	by	qualitative	evaluation	of	RV	free	wall	motion,	qualitative	assessment	of	tricuspid	regurgitation	(TR),	and	by	quantitative	determination	of	the	TR	jet	using	continuous	 wave	 Doppler.	 TR	 jet	 analysis	 was	 then	 correlated	 to	 right	 atrial	pressure	 and	 pulmonary	 artery	 systolic	 pressure	 using	 a	 simplified	 Bernoulli	equation.	The	two	predictors	of	increased	likelihood	of	in-hospital	mortality	among	the	patient	population	were	cancer	(hazard	ratio	of	2.3)	and	moderate	to	severe	RV	systolic	dysfunction	(hazard	ratio	of	6.0).	They	concluded	that	2D	echocardiography	can	be	useful	in	risk	stratification	of	patients	with	RV	dysfunction	and/or	history	of	malignancy	(55).			 It	has	also	been	shown	that	point-of-care	ultrasound	qualitative	assessment	of	RV	strain	in	patients	with	acute	PE	in	an	Emergency	Department	setting	can	have	prognostic	indications.	In	the	first	study	to	examine	non-cardiologist-performed	RV	strain	assessment	for	PE	prognosis,	Taylor	et	al.	performed	a	retrospective	study	of	patients	with	diagnosed	PE	and	had	had	point	of	care	ultrasound	during	their	course	of	care	in	the	emergency	department.		They	used	RV	strain	qualitative	measures	of	RV:LV	size	comparison	(≥1),	RV	wall	hypokinesis,	and	McConnell’s	sign,	and	adverse	clinical	 outcomes	 assessed	 were	 shock	 (systolic	 BP	 <100	 mmHg	 refractory	 to	volume	 loading	 and	 requiring	 vasopressors),	 respiratory	 failure	 requiring	intubation,	 death,	 recurrent	 venous	 thromboembolism,	 clinical	 deterioration	 as	
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evidenced	 by	 transition	 to	 higher	 level	 of	 care,	 and	 major	 bleeding.	 It	 was	determined	 that	RV	strain	on	emergency	physician-performed	ultrasound	was	 the	single	most	 important	 prognostic	 factor	 in	 adverse	 hospital	 events	 (Odds	 Ratio	 =	9.2)	(52).			 Quantitative	 2D	 echocardiography	 measures	 of	 RV	 strain	 have	 also	 been	shown	to	have	prognostic	indication	for	risk-stratification	of	patients	with	acute	PE.	However,	this	research	has	largely	been	investigated	in	the	field	of	cardiology.	It	has	been	shown	that	TAPSE	is	preferable	to	RV:LV	ratio,	and	other	qualitative	measures,	for	 risk	 stratification	 in	 initially	 normotensive	 patients	 with	 acute	 PE	 (46).		Pruszczyk	et	al.	showed	that	TAPSE	was	the	only	independent	predictor	of	“clinical	end-point”	 (CE),	 consisting	of	30-day	PE-related	death	or	 thrombolysis.	Moreover,	normotensive	 patients	 with	 a	 TAPSE	 ≤	 15	 mm	 had	 a	 hazard	 ratio	 of	 27.9	 and	 a	positive	 predictive	 value	 of	 20.9%	 for	 CE	 with	 a	 99%	 negative	 predictive	 value,	while	a	TAPSE	≤	20	mm	had	a	positive	predictive	value	of	9.2%	for	CE	with	a	100%	negative	 predictive	 value.	 Therefore,	 patients	 with	 a	 TAPSE	 ≤	 15	 mm	 can	 be	identified	 as	 high	 risk	 for	 30	 day	 acute	 PE-related	 mortality,	 while	 those	 with	 a	TAPSE	>	20	mm	can	be	identified	as	a	very	low-risk	group	(46).			In	 the	 Emergency	 Department	 setting,	 little	 research	 has	 been	 done	 to	evaluate	 the	 prognostic	 value	 of	 TAPSE	 performed	 by	 emergency	 physicians.	Zanobetti	et	al.	investigated	whether	one	or	more	echocardiographic	indexes	could	predict	 short-term	 evolution	 towards	 RV	 dysfunction	 in	 patients	 affected	 by	 PE,	with	the	goal	of	tailoring	therapy	in	the	first	hours	after	diagnosis	according	to	the	hemodynamic	 profile.	 They	 examined	 sonographic	 signs	 of	 RV	 dysfunction	 at	 the	
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time	of	diagnosis	with	PE	 (confirmed	by	CT),	7	days	after	diagnosis,	 and	1	month	after	diagnosis,	to	determine	improvement	of	RV	systolic	function	over	time.	In	the	patient	 group	with	 low	TAPSE	 (as	 defined	 by	TAPSE	below	 the	mean	 value	 of	 15	mm),	 and	 high	 pulmonary	 artery	 systolic	 pressure	 (PASP)	 (as	 defined	 by	 PASP	above	 the	 mean	 value	 of	 62	 mmHg),	 considerable	 improvement	 of	 RV	 systolic	function	 7	 days	 after	 diagnosis/treatment	 only	 occurred	 if	 the	 patients	 received	thrombolytic	 therapy	 compared	 to	 anticoagulation.	 That	 is	 to	 say,	 normotensive	patients	 in	 that	 category	 that	 received	 Heparin	 only	 did	 not	 regain	 RV	 systolic	function	 within	 one	 week	 of	 diagnosis	 and	 treatment.	 It	 was	 concluded	 that	 an	intermediate-risk	 of	 normotensive	 patients	 with	 depressed	 TAPSE	 and	 elevated	PASP	may	 benefit	 from	 thrombolytic	 therapy	 after	 the	 exclusion	 of	 bleeding	 risk	(47).	 While	 this	 was	 the	 first	 study	 regarding	 the	 assessment	 of	 RV	 dysfunction	using	emergency	physician-performed	echocardiography,	 the	study	only	examined	the	prognostic	value	of	echocardiography	indices	as	they	relate	to	the	improvement	of	RV	function	post	PE	diagnosis	and	therapy,	not	as	they	relate	to	adverse	clinical	outcomes.		
1.3.3	Inter-observer	Reliability	of	TAPSE	As	 previously	 mentioned,	 easy	 and	 reliable	 quantitative	 measures	 of	 right	heart	strain	on	bedside	echo	would	be	an	effective	tool	for	emergency	physicians	for	risk	 stratification	 of	 patients	with	 PE.	 Though	 qualitative	measures	 can	 be	 useful,	the	 inter-observer	 agreement	 is	 not	 always	 strong.	 For	 example,	 a	 retrospective	study	 of	 patients	 presenting	 to	 the	 ED	with	 chest	 pain,	 dyspnea,	 or	 hypotension,	
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who	received	a	limited	bedside	echo	in	the	ED	and	a	subsequent	consultative	echo	within	72	hours,	showed	moderate	agreement	(κ	=	0.44)	for	RV	dilation	(53).		TAPSE	 has	 been	 shown	 to	 have	 good	 inter-observer	 reliability	 across	 a	multitude	 of	 cardiac	 and	 pulmonary	 pathologies,	 including	 inferior	 wall	 MI33,	hypoplastic	 left	 heart	 syndrome54,	 pulmonary	 hypertension	 (41,48),	 and	 simply	correlating	 TAPSE	 to	 tricuspid	 regurgitation	 (TR)	 and	 RVEF	 (57).	 In	 acute	 PE	 of	normotensive	 patients,	 Kopecna	 et	 al.	 demonstrated	 that	 TAPSE	 had	 the	 highest	inter-observer	 reliability	 (κ	 =0.86)	 compared	 to	 other	 qualitative	measures	 of	 RV	strain,	including	that	of	RV	enlargement	by	diameter	(κ	=	0.45)	and	RV	enlargement	by	 RV:LV	 ratio	 (κ	 =	 0.65)	 (45).	 However,	 the	 inter-observer	 reliability	 of	 TAPSE	among	emergency	physicians	has	yet	to	be	investigated.		
1.4	Electrocardiography	in	Acute	Pulmonary	Embolism	
1.4.1	Diagnostic	and	Prognostic	Indication:	The	Daniel	Score	While	 many	 signs	 of	 acute	 right	 heart	 strain	 can	 be	 found	 with	echocardiography,	 as	 previously	 mentioned,	 as	 well	 as	 the	 numerous	 blood	 tests	and	 CT	 imaging	 that	 can	 be	 used	 to	 aid	 in	 the	 workup	 of	 a	 patient	 with	undifferentiated	 dyspnea	 and	 suspected	 PE,	 there	 is	 still	 a	 crucial	 role	 for	electrocardiography	 (ECG)	 in	 the	 diagnostic	 and	prognostic	 evaluation	 of	 patients	with	 acute	 PE.	 ECG	 is	 one	 of	 the	 first	 tests	 performed	 in	 the	 ED	 and	 is	 rapidly	interpretable,	low-risk,	and	inexpensive.	When	one	thinks	of	the	ECG	related	to	PE,	one	generally	thinks	of	the	“textbook”	S1Q3T3.	However,	S1Q3T3	has	been	found	to	be	relatively	insensitive	for	PE	and	its	prevalence	has	been	found	in	variable	rates	among	PE	positive	patients	(11%	to	52%)	(4).	Digby	et	al.,	reviewed	the	ECG	in	the	
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setting	of	PE	literature,	and	found	that	ECG	plays	a	valuable	role	for	prognostication	for	 PE	 (4).	 ECG	 abnormalities	 were	 found	 to	 be	 reasonable	 predictors	 of	hemodynamic	 decompensation	 (58),	 RV	 dysfunction	 (59),	 elevated	 mean	pulmonary	 arterial	 pressure	 (60),	 in-hospital	 complication	 (61,62),	 cardiogenic	shock	(63),	and	mortality	(64,65).		As	 previously	mentioned,	 the	 pathophysiology	 of	 PE	may	 lead	 to	 ischemic	changes	in	the	right	ventricular	myocardium	due	to	increased	demand.	ECG	changes	may	thus	reflect	depolarization	abnormalities	(such	as	 in	RBBB),	or	repolarization	abnormalities	 (such	 as	 in	 ST	 segment	 elevation,	 depression,	 or	 inverted	T	waves)	(4).	ECG	abnormalities	that	may	be	observed	in	acute	PE,	and	have	been	evaluated	in	 the	 literature	 include	 sinus	 tachycardia,	 RBBB,	 T	 wave	 inversions,	 S1Q3T3,	 ST	depression	(STD),	ST	elevation	(STE),	axis	deviation,	supraventricular	tachycardia,	P	pulmonale,	the	QR	sign,	long	QT,	QRS	fragmentation	and	Brugada	phenocopy	(4).		In	 2001,	 Daniel	 et	 al.	 created	 a	 comprehensive	 scoring	 system	 for	 ECG	findings	in	acute	PE	(66).	The	scoring	system	was	as	follows	(with	points	awarded	shown	in	brackets):	sinus	tachycardia	(2),	incomplete	RBBB	(2),	complete	RBBB	(3),	TWI	in	V1-V4	(0-12	depending	on	depth),	S	wave	in	I	(0),	Q	wave	in	III	(1),	TWI	in	III	(1),	 S1Q3T3	 (2).	 With	 21	 being	 the	 maximum	 score,	 a	 cutoff	 of	 10	 was	 23.5%	sensitive	and	97.7%	specific	for	the	recognition	of	severe	pulmonary	hypertension	secondary	 to	PE.	They	 found	 the	derived	ECG	score	 increases	with	 the	 severity	of	pulmonary	hypertension	from	PE	(66).		Though	 the	 Daniel	 Score	 provided	 a	 comprehensive	 scoring	 system	 for	diagnosing	pulmonary	hypertension	 in	patients	with	suspected	PE,	 it	did	not	yield	
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prognostic	value	for	the	use	of	risk	stratification.	Additionally,	Digby’s	review	of	the	literature	 illustrated	 that	 findings	 not	 included	 in	 the	 Daniel	 Score,	 TWIs	 in	 non-precordial	 leads,	 STD,	 STE,	 the	 QR	 sign,	 QRS	 fragmentation	 and	 atrial	 fibrillation,	yielded	prognostic	value	for	patients	with	acute	PE.	In	particular,	it	was	shown	that	patients	 with	 acute	 PE	 and	 right	 ventricular	 dysfunction	 having	 ischemic	 ECG	patterns	 had	 higher	 mortality	 than	 patients	 with	 acute	 PE	 and	 right	 ventricular	dysfunction	without	ischemic	ECG	patterns	(67).		
1.4.2	Correlating	Echocardiography	and	Electrocardiography:	TwiST		 With	the	continued	expansion	of	bedside	echo	in	the	ED	as	a	diagnostic	and	prognostic	exam	 for	patients	with	 suspected	PE,	 the	ability	 to	 combine	 laboratory	results,	 echo	 findings	 and	 ECG	 findings	 in	 risk	 stratification	 has	 dramatically	increased.	Thus	 far,	 one	 study	has	 examined	 correlating	echo	and	ECG	 findings	 to	short-term	adverse	clinical	outcomes	in	an	emergency	room	setting.	In	particular,	a	simplified	version	of	the	Daniels	Score,	the	TwiST	score,	was	derived	and	correlated	to	RV	strain	and	adverse	clinical	outcomes	(68).	Hariharan	et	al.	defined	RV	strain	based	 on	 echocardiography,	 CTPA,	 or	 biomarker	 results.	 Their	 echocardiography	criteria	 of	 RV	 strain	 consisted	 of	 RV	 hypokinesis,	 dilation,	 and	 abnormal	interventricular	 septal	movement.	They	derived	a	10-point	ECG	 score	 (TwiST)	 for	risk	stratification	based	on	modifying	the	Daniel	Score.	The	scoring	system	was	as	follows	(with	points	awarded	shown	in	brackets):	T	wave	inversions	in	V1-V3	(5),	S	wave	in	lead	I	(2),	sinus	tachycardia	(3).	Adverse	clinical	outcomes	were	measured	after	5	days	(68).		
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They	found	that	they	could	effectively	risk	stratify	85%	of	patients	with	acute	PE.	A	TwiST	score	of	≤	2	excluded	RV	strain	with	85%	sensitivity	whereas	a	score	of	≥	5	was	93%	specific	for	RV	strain	in	patients	with	PE.	Additionally,	the	same	cut-off	values	were	76%	sensitive	and	87%	specific	for	5-day	adverse	clinical	events	(68).	It	should	be	noted	that	echoes	were	performed	within	3	days	after	diagnosis	of	acute	PE,	 PE	 negative	 counterparts	 were	 not	 enrolled,	 RV	 strain	 identified	 by	echocardiography	only	accounted	for	35%	of	confirmed	RV	strain	in	the	population,	and	all	echo	measurements	of	RV	strain	were	qualitative	in	nature.	While	the	study	results	provide	immense	value	to	the	emergency	physician,	they	also	provide	clear	indication	 to	 further	 investigate	 the	 value	 of	 expanding	 the	 role	 of	 bedside	echocardiography	in	a	prospective	manor.	A	quantitative	measure	of	RV	strain	such	as	TAPSE,	with	known	prognostic	value,	that	can	be	correlated	to	ECG	findings	and	adverse	clinical	events	can	be	an	essential	tool	in	risk	stratification	of	patients	with	acute	PE.			
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2.	Statement	of	Purpose	In	 patients	 with	 PE,	 TAPSE	 has	 been	 shown	 to	 correlate	 strongly	 with	 other	echocardiography	measurements	of	RV	function.	It	has	also	been	shown	to	predict	adverse	 clinical	 events.	 Though	 the	 use	 of	 TAPSE	 in	 assessing	 patients	 with	suspected	PE	has	been	recently	 reported	 in	 the	 literature,	 thus	 far	only	one	study	has	 been	 published	 regarding	 its	 use	 by	 emergency	medicine	 physicians	 (EMPs).	Additionally,	no	study	has	analyzed	the	comparison	of	electrocardiography	scoring	assessments	for	right	heart	strain	to	TAPSE	in	suspected	pulmonary	embolism.	This	study	aims	to	examine	the	diagnostic	predictability	of	the	use	of	TAPSE	by	EMPs	in	suspected	 PE,	 and	 the	 correlation	 of	 TAPSE	 to	 other	 established	electrocardiographic	predictors	of	right	heart	strain.	Additionally,	this	study	aims	to	investigate	 the	 use	 of	 these	 parameters	 in	 predicting	 clinical	 outcome	 of	 patients	with	PE.		We	 hypothesized	 high	 Daniels	 scores	 (≥10)	 or	 high	 TwiST	 scores	 (≥5)	 would	correlate	to	having	RV	systolic	dysfunction	determined	by	TAPSE,	and	that	Daniels	scores	and	Twist	scores	would	be	higher,	while	TAPSE	scores	would	be	lower,	in	PE	positive	 patients.	 We	 also	 hypothesized	 that	 patients	 who	 received	 PE	 “elevated	care”	 (PEEC),	 defined	 as	 the	 need	 for	 thrombolysis,	 pressors,	 and/or	 ICU	 stay	 ≥1	day,	 would	 have	 higher	 Daniels	 scores	 and	 TwiST	 scores,	 and	 lower	 TAPSE	measurements	than	those	who	did	not.	This	 study	 aims	 to	 expand	 the	 scope	 of	 practice	 for	 EMPs	 and	 provide	 a	diagnostic	tool	in	evaluating	and	treating	patients	presenting	with	undifferentiated	dyspnea.		
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3.	Methods	
3.1	Design	We	 performed	 this	 study	 at	 the	 emergency	 department	 (ED)	 of	 Yale-New	Haven	 Hospital	 (YNHH),	 a	 large,	 urban,	 academic	 hospital	 that	 sees	 more	 than	80,000	 ED	 visits	 per	 year	 and	 has	 an	 intensive	 care	 unit	 (ICU)	 admission	 rate	 of	approximately	 15%.	 The	 design	 of	 the	 study	 was	 a	 prospective,	 blinded,	observational	 cohort	 study	 of	 adult	 (age	 ≥	 18)	 ED	 patients	 with	 suspected	pulmonary	 embolism.	 IRB	 approval	 was	 obtained,	 and	 enrollment	 was	nonconsecutive,	and	based	on	convenience	of	ED	research	staff.	Most	patients	were	enrolled	between	the	hours	of	7	AM	and	8	PM	during	weekdays	during	the	period	of	March	2015	to	September	2015.	Research	staff	screened	patients	for	who	computed	tomography	 pulmonary	 angiography	 (CTPA)	 was	 ordered	 by	 the	 attending	physician.	 Patients	 were	 then	 approached	 for	 eligibility	 and	 enrollment	 with	informed	 consent,	 and	 bedside	 echocardiography	 was	 performed	 as	 soon	 as	conveniently	possible,	without	delaying	standard	patient	care.		
3.2	Eligibility	Criteria	Enrollment	criteria	 included	any	adult	patient	for	whom	CTPA	was	ordered	and	 completed	 for	 concern	 of	 pulmonary	 embolism.	 Board	 certified	 radiologists	interpreted	all	radiographic	findings	as	a	part	of	routine	clinical	care.	Patients	were	excluded	 from	 the	 study	 if	 they	were	 under	 18,	 prisoners,	 wards	 of	 the	 state,	 or	unable	to	provide	informed	consent.				
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3.3	Echocardiography	Subjects	underwent	transthoracic	echocardiography	by	trained	ED	providers	using	 a	 Phillips	 Sparq	 Ultrasound	 System.	 Five	 views	 were	 obtained	 using	 the	phased	 array	 probe	 and	 images	 were	 recorded.	 The	 views	 obtained	 were	 the	parasternal	 long	 view,	 parasternal	 short	 view,	 apical	 4	 chamber	 view,	 subxiphoid	view	 and	 an	 inferior	 vena	 cava	 (IVC)	 view.	 The	 following	 measures	 were	 either	qualitatively	or	quantitatively	recorded:	RV	dilation	(ratio	greater	than	1:1	with	LV),	McConnell’s	 sign,	 presence	 of	 tricuspid	 regurgitation	 (TR),	 velocity	 of	 tricuspid	regurgitation	jet,	IVC	collapsibility	and	TAPSE.	TR	jet	velocity	was	determined	using	continuous	 wave	 Doppler	 in	 the	 apical	 4	 chamber	 view.	 TAPSE	 was	 determined	using	Motion	mode	(M-mode)	over	 the	 tricuspid	annulus	against	 the	RV	 free	wall.	Total	 displacement	 was	 measured	 from	 end-diastole	 to	 end-systole,	 with	 the	distance	being	determined	by	the	vertical	change	from	the	top	of	the	trough	to	top	of	 the	 peak	 on	 the	 wave	 form	 seen	 in	 M-mode	 (figure	 1).	 Low	 TAPSE	 was	determined	to	be	≤	17mm.	Sonographers	were	blinded	to	patient	CTPA	results.	
3.4	Electrocardiography	A	 standard	 12-lead	 ECG	 was	 performed	 in	 the	 ED	 for	 all	 but	 5	 patients	enrolled	 in	 the	 study.	 ECGs	 were	 interpreted	 by	 a	 single,	 research	member,	 who	trained	in	interpreting	ECGs	for	5	months	prior	to	interpreting	the	ECGs	of	enrolled	patients	in	this	study.	The	ECGs	were	assessed	and	scored	for	Daniels	Criteria:	sinus	tachycardia	 (2),	 incomplete	 RBBB	 (2),	 complete	 RBBB	 (3),	 TWI	 in	 V1-V4	 (0-12	depending	on	depth),	S	wave	in	I	(0),	Q	wave	in	III	(1),	TWI	in	III	(1),	S1Q3T3	(2),	for	a	possible	total	of	21	points.	ECGs	were	also	assessed	and	scored	for	TwiST	Criteria:	
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T	wave	 inversions	 in	 V1-V3	 (5),	 S	wave	 in	 lead	 I	 (2),	 sinus	 tachycardia	 (3),	 for	 a	possible	 total	 of	 10	 points.	 The	 ECG	 reader	 was	 blinded	 to	 patient	 outcome	 and	TAPSE	measurement	while	reviewing	and	scoring	ECGs.	Figure	2	shows	an	example	of	a	patient	who	was	PE	positive	and	had	high	Daniels	and	TwiST	scores	of	20	and	10	respectively.		
3.5	Prognostic	Evaluation:	PE	Elevated	Care	(PEEC)	Patients	 diagnosed	 with	 pulmonary	 embolism	 were	 followed	 for	 up	 to	 30	days	as	inpatients	and	using	death	registries	to	determine	any	association	between	findings	on	ECG	and	bedside	echo	to	morbidity,	mortality,	and	level	of	care	required.	These	included	factors	such	as	disposition	(ICU,	step-down	unit,	floor),	requirement	of	pressors,	requirement	of	thrombolysis,	 length	of	stay	and	mortality.	 In	addition,	we	stratified	patients	with	 these	 indicators	 into	PE	positive	patients	 that	 required	PE	Elevated	Care	(PEEC),	defined	as	the	need	for	thrombolysis,	pressors,	and/or	ICU	stay	≥1	day,	and	patients	who	did	not	require	PEEC.			
3.6	Statistical	Analysis	
3.6.1	Diagnosis	of	PE	Diagnostic	characteristics	of	 sensitivity,	 specificity,	positive	 likelihood	ratio,	negative	 likelihood	 ratio,	 and	 positive	 and	 negative	 predictive	 values,	 were	determined	 for	 diagnosing	 patients	with	 PE	using	 the	Daniels	 score,	 TwiST	 score,	and	 2	 different	 TAPSE	 values.	 One	 TAPSE	 value	 of	 17	 mm	 was	 used	 for	 higher	specificity,	and	a	value	of	21	mm	was	used	for	higher	sensitivity.	Statistical	analyses	were	calculated	using	the	online	software	VassarStats	(vassarstats.net).	
	
		
29	
3.6.2	Comparison	of	TAPSE	and	ECG		Diagnostic	characteristics	of	 sensitivity,	 specificity,	positive	 likelihood	ratio,	negative	 likelihood	 ratio,	 and	 positive	 and	 negative	 predictive	 values	 were	determined	for	the	Daniels	and	TwiST	scores	ability	to	diagnose	right	heart	strain	as	determined	by	a	“low	TAPSE”	of	≤17	mm.	Statistical	analyses	were	calculated	using	the	online	software	VassarStats	(vassarstats.net).	Additionally,	patients	were	stratified	into	“low	TAPSE”	and	“normal	TAPSE”	groups.	Mean	ECG	scores	for	the	Daniels	and	TwiST	criteria	were	compared	between	groups	using	student’s	t-test.	Patients	were	also	stratified	into	PE	positive	and	PE	negative	groups.	 Mean	 TAPSE	 measurements,	 and	 Daniels	 score	 and	 TwiST	 scores	 were	compared	between	groups	using	student’s	t-test.	Statistical	analyses	were	calculated	using	the	online	software	VassarStats	(vassarstats.net).	
3.6.3	TAPSE,	ECG	and	PEEC	Mean	TAPSE,	Daniels	and	TwiST	scores	and	relative	risks	were	calculated	for	patients	who	received	“elevated	care”	compared	to	those	who	did	not.	The	relative	risk	of	 low	TAPSE	 (≤17	mm)	and	high	Daniels	 (≥10)	 and	TwiST	 (≥5)	 for	 elevated	care	 were	 also	 compared.	 Statistical	 analyses	 were	 calculated	 using	 the	 online	software	VassarStats	(vassarstats.net).	
3.6.4	The	Role	of	Research	Study	Members	In	regards	to	the	methods	described	above,	I	enrolled	90	of	the	110	patients	in	 the	 research	 study	 and	 performed	 their	 echocardiogram	 in	 the	 emergency	department.	Additionally,	 I	 interpreted	all	of	 the	ECGs	 for	 the	 study	population	as	well	as	performed	all	statistical	analyses.	Patients	were	also	enrolled	by	Dr.	 James	
		
30	
Daley,	Dr.	Michael	Kennedy	Hall,	Dr.	Joseph	Pare,	Dr.	Rachel	Liu,	Dr.	Andrew	Taylor	and	Dr.	Chris	Moore.			
4.	Results	
4.1	Enrollment	Demographics	and	Hospital	Course	We	enrolled	 110	patients	 in	 total,	 45	men	 and	65	women,	 and	23	patients	were	diagnosed	with	a	pulmonary	embolism	(PE	positive).	Of	the	23	patients	with	PE,	 13	 were	 men	 and	 10	 were	 women.	 Of	 the	 110	 patients	 enrolled,	 105	 had	recorded	 ECG’s,	 and	 all	 underwent	 bedside	 echocardiography.	 Enrolled	 patients	ranged	from	18	to	90	years	old,	with	an	average	age	of	58.6	(SD±17.4)	years	old.	PE	positive	patients	had	an	average	age	of	63.4	(SD±15.1)	years	old,	while	PE	negative	patients	 had	 an	 average	 age	 of	 57.4	 (SD±17.9)	 years	 old.	 23	 patients	 were	discharged	 from	 the	Emergency	Department	 (1	who	was	PE	positive),	30	patients	were	 admitted	 to	 the	 floor	 (13	 who	 were	 PE	 positive)	 and	 24	 were	 admitted	 to	either	 the	 step	 down	 unit	 (SDU)	 or	 intensive	 care	 unit	 (ICU)	 (9	 who	 were	 PE	positive)	 (Table	 1).	 	 Other	 dispositions	 of	 patients	 that	 were	 not	 tracked	 include	telemetry	observation	and	admission	 to	 the	chest	pain	center.	The	mean	 length	of	stay	 for	 enrolled	 patients	was	 3.9	 (SD±5.4)	 days.	 The	mean	 length	 of	 stay	 for	 PE	positive	patients	was	6.7	(SD±6)	days,	while	the	mean	length	of	stay	for	PE	negative	patients	was	3.3	(SD±5.1)	days	(Table	1).	
4.2	Diagnosis	of	PE	When	 total	 Daniels	 score	was	 evaluated	 for	 the	 ability	 to	 diagnose	 PE,	 we	first	began	with	the	ability	of	a	 low	Daniels	score	(≤2)	to	rule	out	a	PE,	that	is,	the	ability	 to	 “diagnose”	 PE	 negative.	 A	 Daniels	 score	 of	 ≤2	was	 58%	 (95%	 CI,	 46%-
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58%)	sensitive	and	50%	(95%	CI,	28%-72%)	specific	 for	determining	PE	negative	patients.	 In	 addition,	 it	 had	a	positive	 likelihood	 ratio	of	1.2,	 a	negative	 likelihood	ratio	of	0.87,	a	positive	predictive	value	of	83%	and	a	negative	predictive	value	of	22%	(Table	2).	Then,	the	ability	of	the	Daniels	score	to	predict	PE	was	evaluated	in	an	 increasing	fashion,	beginning	with	Daniels	score	of	≥3,	 followed	by	cutoffs	of	7,	10,	12	and	17.	Sensitivities	decreased	from	50%	(95%	CI	28%-72%)	to	13%	(95%	CI	2%-42%)	among	 these	groups,	while	 specificities	 increased	 from	58%	(95%	CI	46%-68%)	 to	 99%	 (95%	 CI	 93%-100%)	 (Table	 2).	 Positive	 likelihood	 ratios	increased	 from	 1.2	 (0.7-1.95)	 to	 12	 (1.2-124),	 while	 negative	 likelihood	 ratios	showed	 varying	 ranges	 among	 cutoff	 values	 (Table	 2).	 Positive	 predictive	 values	increased	from	22%	(11%-37%)	to	67%	(13%-98%)	and	negative	predictive	values	increased	from	83%	(71%-91%)	to	87%	(79%-93%)	(Table	2).	When	total	TwiST	score	was	evaluated	for	the	ability	to	diagnose	PE,	similar	to	with	the	Daniels	score,	we	first	began	with	the	ability	of	a	low	TwiST	score	(≤2)	to	rule	out	a	PE,	that	is,	the	ability	to	“diagnose”	PE	negative.	A	TwiST	score	of	≤2	was	63%	 (95%	 CI,	 52%-73%)	 sensitive	 and	 50%	 (95%	 CI,	 27%-73%)	 specific	 for	determining	 PE	 negative	 patients.	 In	 addition,	 it	 had	 a	 positive	 likelihood	 ratio	 of	1.4,	 a	 negative	 likelihood	 ratio	 of	 0.79,	 a	 positive	 predictive	 value	 of	 86%	 and	 a	negative	predictive	value	of	22%	(Table	3).	The	ability	of	the	TwiST	score	to	predict	PE	 was	 evaluated	 in	 an	 increasing	 fashion,	 beginning	 with	 TwiST	 score	 of	 ≥3,	followed	by	cutoffs	of	5,	7,	and	8.	Sensitivities	decreased	from	50%	(95%	CI	27%-73%)	to	29%	(95%	CI	12%-52%)	among	these	groups,	while	specificities	increased	from	 63%	 (95%	 CI	 52%-73%)	 to	 93%	 (95%	 CI	 85%-97%)	 (Table	 3).	 Positive	
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likelihood	ratios	increased	from	1.4	(0.8-2.3)	to	4	(1.4-11),	while	negative	likelihood	ratios	 showed	 varying	 ranges	 among	 cutoff	 values	 (Table	 3).	 Positive	 predictive	values	increased	from	22%	(11%-38%)	to	50%	(22%-78%)	and	negative	predictive	values	decreased	from	86%	(74%-93%)	to	84%	(74%-90%)	(Table	3).	With	regard	to	the	ability	of	TAPSE	to	diagnose	PE,	TAPSE	values	≤	17	mm	were	 57%	 (95%	CI	 34%-77%)	 sensitive	 and	 87%	 (95%	CI	 78%-93%)	 specific	 in	diagnosing	 PE	 (Table	 4).	 Additionally,	 the	 cutoff	 of	 ≤	 17	 mm	 had	 a	 positive	likelihood	 ratio	 of	 4.3	 (2.2-8.3)	 and	 a	 negative	 likelihood	 ratio	 of	 0.5	 (0.3-0.8),	 as	well	 as	 a	 positive	 predictive	 value	 of	 54%	 (33%-74%)	 and	 a	 negative	 predictive	value	of	 88%	 (79%-94%).	TAPSE	values	≤	21	mm	were	79%	 (95%	CI	57%-92%)	sensitive	and	67%	(95%	CI	55%-76%)	specific	 in	diagnosing	PE.	Additionally,	 the	cutoff	 of	 ≤	 21	mm	 had	 a	 positive	 likelihood	 ratio	 of	 2.4	 (1.6-3.4)	 and	 a	 negative	likelihood	 ratio	 of	 0.31	 (0.14-0.69),	 as	well	 as	 a	 positive	 predictive	 value	 of	 40%	(27%-56%)	and	a	negative	predictive	value	of	92%	(81%-97%)	(Table	4).	
4.3	Comparison	of	ECG	Scoring	and	TAPSE	Measurements	In	 evaluating	 a	 correlation	 between	 higher	 Daniels	 and	 TwiST	 scores	 and	lower	 TAPSE	 scores,	 the	 ability	 of	 Daniels	 and	 TwiST	 scores	 to	 “diagnose”	 a	 low	TAPSE	 (≤17	mm)	was	determined.	 Similarly,	 in	 the	evaluation	of	diagnosing	PE,	 a	Daniels	score	of	≤2	was	evaluated	to	rule	out	a	low	TAPSE.	A	Daniels	score	of	≤2	was	60%	 (95%	 CI,	 48%-71%)	 sensitive	 and	 77%	 (95%	 CI,	 55%-92%)	 specific	 for	determining	 high	 TAPSE	 patients.	 In	 addition,	 it	 had	 a	 positive	 likelihood	 ratio	 of	2.64,	 a	 negative	 likelihood	 ratio	 of	 0.5,	 a	 positive	 predictive	 value	 of	 91%	 and	 a	negative	predictive	value	of	35%	(Table	5).	Then,	the	ability	of	the	Daniels	score	to	
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predict	 low	TAPSE	was	evaluated	 in	an	 increasing	 fashion,	beginning	with	Daniels	score	of	≥3,	followed	by	cutoffs	of	7,	10,	12	and	17.	Sensitivities	decreased	from	77%	(95%	 CI	 55%-92%)	 to	 13%	 (95%	 CI	 3%-34%)	 among	 these	 groups,	 while	specificities	increased	from	60%	(95%	CI	48%-71%)	to	100%	(95%	CI	95%-100%)	(Table	 5).	 Positive	 likelihood	 ratios	 increased	 from	 2.64	 (1.2-5.8)	 to	 17	 (2-140),	while	negative	likelihood	ratios	showed	varying	ranges	among	cutoff	values	(Table	5).	 Positive	 predictive	 values	 increased	 from	 35%	 (22%-50%)	 to	 100%	 (29%-100%)	 and	 negative	 predictive	 values	 decreased	 from	 91%	 (71%-97%)	 to	 80%	(70%-87%)	(Table	5).	A	TwiST	score	of	≤2	was	70%	(95%	CI,	68%-79%)	sensitive	and	87%	(95%	CI,	 66%-97%)	 specific	 for	 determining	 high	 TAPSE	 patients.	 In	 addition,	 it	 had	 a	positive	 likelihood	 ratio	 of	 5.34,	 a	 negative	 likelihood	 ratio	 of	 0.35,	 a	 positive	predictive	 value	 of	 95%	 and	 a	 negative	 predictive	 value	 of	 45%	 (Table	 6).	 The	ability	of	the	TwiST	score	to	predict	low	TAPSE	was	also	evaluated	in	an	increasing	fashion,	 beginning	 with	 a	 TwiST	 score	 of	 ≥3,	 followed	 by	 cutoffs	 of	 5,	 7,	 and	 8.	Sensitivities	decreased	 from	70%	(95%	CI	68%-79%)	to	39%	(95%	CI	20%-61%)	among	these	groups,	while	specificities	increased	from	70%	(95%	CI	68%-79%)	to	96%	 (95%	CI	 89%-99%)	 (Table	6).	 Positive	 likelihood	 ratios	 increased	 from	5.34	(2-15)	to	10.3	(3-35),	while	negative	likelihood	ratios	showed	varying	ranges	among	cutoff	values	(table	6).	Positive	predictive	values	increased	from	45%	(30%-62%)	to	75%	(43%-95%)	and	negative	predictive	values	decreased	from	95%	(86%-99%)	to	84%	(75%-91%)	(Table	6).	
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Patients	with	 low	TAPSE	 had	 a	mean	Daniels	 score	 of	 7.26	 (SD±5.9)	while	patients	with	a	TAPSE	>	17	mm	had	a	mean	Daniels	score	of	2.5	(SD±2.5).	Patients	with	 low	 TAPSE	 had	 a	mean	 TwiST	 score	 of	 5.52	 (SD±3.3)	 while	 patients	 with	 a	TAPSE	>	17	mm	had	a	mean	TwiST	score	of	1.79	(SD±2.4).	Mean	Daniels	scores	and	TwiST	 scores	 were	 significantly	 different	 between	 low	 and	 high	 TAPSE	 groups	(p<0.0001),	and	high	Daniels	and	TwiST	scores	correlated	to	low	TAPSE	(p<0.0001	and	 p=0.0002	 respectively).	 PE	 positive	 (PE+)	 patients	 had	 a	 significantly	 lower	mean	 TAPSE	 value	 of	 17.6	 mm	 (SD±5.0)	 compared	 to	 22.2	 mm	 (SD±5.3)	 in	 PE	negative	 (PE-)	 patients	 (p=0.0003).	 PE+	 patients	 had	 a	 significantly	 higher	 mean	Daniels	 score	 of	 5.95	 (SD±6.05)	 compared	 to	 2.96	 (SD±3.24)	 in	 PE-	 patients	(p=0.0024).	PE+	patients	had	a	significantly	higher	TwiST	score	of	4.38	(SD±3.46)	compared	to	2.24	(SD±2.77)	in	PE-	patients	(p=0.0033)	(Table	7).	
4.4	PEEC	v.	Non-PEEC	Mean	TAPSE	for	patients	requiring	PEEC	was	15.2	mm	(SD±5.07)	compared	to	 19.4	 mm	 (SD±4.27)	 for	 those	 who	 did	 not	 (p=0.047).	 Mean	 Daniels	 score	 for	patients	requiring	PEEC	was	8.2	(SD±5.4)	compared	to	3.9	(SD±6.1)	for	those	who	did	 not	 (p=0.11).	 Mean	 TwiST	 for	 patients	 requiring	 PEEC	 was	 6.6	 (SD±3.5)	compared	 to	 3.0	 (SD±2.96)	 for	 those	 who	 did	 not	 (p=0.020).	 TAPSE	 ≤17	 mm,	Daniels	≥10,	and	TwiST	≥5	had	increased	risks	of	6.9	(p=0.045),	2.0	(p=0.11)	and	4.4	(p=0.025)	respectively	for	requiring	PEEC	(Table	8).	
5.	Discussion	In	 the	 context	of	using	echocardiography	and	electrocardiography	 to	aid	 in	the	diagnosis	of	PE	in	suspected	patients,	it	was	found	that	high	Daniels	and	TwiST	
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scores	were	 specific	 for	 diagnosing	 PE	 in	 this	 patient	 population.	 A	Daniels	 score	≥10	and	a	TwiST	score	≥7	were	94%	and	90%	specific	for	PE	respectively.	Though	this	study	had	a	relatively	small	enrollment,	and	specifically,	a	small	number	of	PE	positive	 patients,	 the	 trends	 in	 increasing	 specificity	 with	 increasing	 TwiST	 and	Daniels	 score	may	 relate	 to	 their	 ability	 to	detect	 right	heart	 strain	 in	PE	positive	patients.	This	finding	correlates	well	with	the	prior	literature	regarding	the	Daniels	and	 TwiST	 scores.	 As	 Daniels	 found	 that	 an	 increase	 in	 his	 derived	 ECG	 score	corresponded	to	 increasing	severity	of	pulmonary	hypertension	from	PE	(66),	and	Hariharan	 et	 al.	 showed	 that	 the	 TwiST	 score	 effectively	 risk	 stratified	 85%	 of	patients	with	acute	PE	(68),	it	 is	reasonable	to	conclude	that	higher	Daniels	scores	and	 TwiST	 scores	 in	 a	 patient	 population	 with	 suspected	 pulmonary	 embolism	would	aid	in	detection	of	RHS	in	those	with	acute	pulmonary	embolism.			When	analyzing	 the	utility	of	TAPSE	 in	diagnosing	PE,	 the	 cutoff	 of	17	mm	yielded	a	higher	specificity	for	PE,	however	the	sensitivity	was	low.	The	sensitivity	was	 increased	 to	79%	when	21	mm	was	used	as	a	 cutoff,	however	 this	decreased	the	 specificity	 to	 67%.	 This	may	 be	 indicative	 of	 the	 utility	 of	 differing	 ranges	 of	TAPSE	values	that	likely	correspond	to	the	degree	of	RHS.	It	may	be	useful	to	have	separate	cutoff	values	as	seen	 in	 this	study	to	maximize	sensitivity	and	specificity.	That	 is,	 a	 TAPSE	 less	 than	 17	mm	may	 be	 useful	 for	 ruling	 in	 PE,	while	 a	 TAPSE	greater	than	21	mm	may	be	useful	at	ruling	out	PE.	An	“intermediate	zone”	between	17	and	21	mm		may	exist	in	which	clinical	judgement	and	further	testing	would	be	useful.	 That	 said,	 this	 study	 only	 examined	 those	 cutoffs	 at	 17	 mm	 and	 21	 mm.	Further	research	with	a	larger	population	would	be	beneficial	in	order	to	determine	
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the	best	 values	 to	optimize	 sensitivity	 and	 specificity	 in	diagnosing	PE	 in	patients	with	suspected	PE.	These	cutoff	values,	however,	are	consistent	with	prior	literature	in	 the	use	of	TAPSE	as	 a	diagnostic	 tool	 for	RV	dysfunction.	An	optimal	 cutoff	 for	diagnosing	RV	dysfunction	using	TAPSE	has	been	suggested	to	be	<	17.5	mm	(31),	while	 an	 optimal	 cutoff	 for	 concluding	 normal	 biventricular	 function	 has	 been	suggested	to	be	>	20	mm	(33).	When	stratifying	PE	positive	and	PE	negative	patients,	it	was	determined	that	PE	 positive	 patients	 had	 significantly	 lower	 TAPSE	 measurements,	 as	 well	 as	significantly	 higher	 Daniels	 and	 TwiST	 scores.	 	 It	 should	 be	 emphasized	 that	 the	patients	 in	 this	 study	were	 all	 suspected	of	 having	 a	PE	 to	 the	point	 at	which	 the	attending	 physician	 ordered	 a	 CTA/PE	 protocol.	 Thus,	 it	 is	 important	 to	 keep	 in	mind	that	these	diagnostic	tools	certainly	cannot	make	a	diagnosis	of	PE	alone,	but	rather	 can	be	used	 in	 the	 context	of	 a	patient	with	 suspected	PE	 to	 rule	 in	or	out	evidence	of	 right	heart	 strain.	This	 is	 to	 say,	 among	any	patient,	 these	 tools	 likely	have	 low	 sensitivity	 and	 specificity	 for	 diagnosing	 PE,	 but	 are	 likely	 useful	 in	diagnosing	right	heart	strain.	In	a	patient	with	evidence	of	right	heart	strain	either	by	Daniels	score	or	TwiST	score,	by	TAPSE	measurement,	or	by	some	combination,	for	 whom	 PE	 is	 on	 the	 differential,	 these	 tools	 may	 help	 aid	 in	 the	 work	 up	 or	diagnosis	of	PE.		Additionally,	 it	 was	 shown	 that	 increasing	 Daniels	 and	 TwiST	 scores	correlate	well	to	RHS	as	defined	by	low	TAPSE.	When	correlating	Daniels	and	TwiST	scores	 to	 measured	 TAPSE	 values,	 lower	 Daniels	 and	 TwiST	 scores	 had	 higher	sensitivities	of	ruling	out	a	low	TAPSE	while	higher	Daniels	and	TwiST	scores	were	
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more	 specific	 for	 ruling	 in	 a	 low	TAPSE.	Though	 this	was	 expected	 as	 all	 of	 these	modalities	 have	 been	 linked	 to	 right	 heart	 strain,	 it	 was	 encouraging	 to	 find	 that	trends	 existed,	 as	 TAPSE	 is	more	 a	measure	 of	 dynamic	 function	 than	what	may	conventionally	 be	 used	 to	 diagnose	 right	 heart	 strain	 (RV>LV	 on	 CT	 or	 echo).	Additionally,	 it	appears	as	 though	 the	TwiST	score	provided	better	sensitivity	and	the	 Daniels	 score	 provided	 better	 specificity	 in	 diagnosing	 RV	 dysfunction	 as	indicated	by	low	TAPSE.	This	is	likely	due	to	the	nature	of	the	two	scoring	systems,	with	the	Daniels	score	being	far	more	comprehensive	than	the	TwiST.	With	only	3	items,	 it	 seems	 the	TwiST	score	has	 the	most	pertinent	elements	 to	 rule	out	 right	heart	strain,	that	is,	tachycardia,	strain	on	the	RV	conduction	system	as	evidenced	by	an	 S	 wave	 in	 lead	 I,	 and	 ischemic	 changes	 as	 evidenced	 by	 T-wave	 inversion	 in	precordial	 leads	 V1-V3.	 A	 TwiST	 score	 <3	 was	 87%	 sensitive	 in	 ruling	 out	 a	 low	TAPSE	compared	to	77%	using	the	Daniels	score.	With	regard	to	specificity,	due	to	the	comprehensiveness	of	the	Daniels	score,	it	had	increased	specificity	for	ruling	in	low	 TAPSE	 values.	 Both	 a	 Daniels	 score	 of	 ≥10,	 and	 a	 TwiST	 score	 of	 ≥8	 had	specificities	of	96%.	However,	because	the	Daniels	score	is	more	inclusive	and	has	many	different	iterations	of	point	totals,	specificity	was	able	to	be	increased	to	99%	and	100%	for	scores	≥12	and	≥17	respectively.	When	stratifying	patients	 into	 low	TAPSE	values	(≤17	mm)	and	high	TAPSE	values,	patients	with	low	TAPSE	values	had	significantly	higher	mean	Daniels	and	TwiST	scores.	This	 finding	corroborates	 the	value	 of	 TAPSE	 as	 a	 marker	 for	 RV	 systolic	 function,	 as	 well	 as	 the	 ECG	 scoring	criteria	 as	 being	 predictive	 of	 RV	 strain.	 Moreover,	 we	 found	 additional	corroboration	with	mean	Daniels	 and	TwiST	 scores	when	 stratifying	patients	 into	
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low	 and	 high	 TAPSE	 groups,	 and	 then	 PE	 positive	 and	 PE	 negative	 groups.	Mean	Daniels	 and	 TwiST	 scores	were	 significantly	 higher	 in	 the	 low	 TAPSE	 group,	 and	significantly	higher	in	the	PE	positive	group.	Additionally,	mean	TAPSE	values	were	significantly	 lower	 in	 the	 PE	 positive	 group	 compared	 to	 the	 PE	 negative	 group.	Again,	 this	 highlights	 the	 utility	 of	 ECG	 scoring	 and	 TAPSE	 in	 detecting	 RHS	 non-invasively.	 This	 intuitively	makes	 sense	 for	 patients	 with	 suspected	 PE	 in	 that	 in	order	to	have	a	suspicion	of	PE	as	a	diagnosis,	the	patients	are	likely	symptomatic.	The	clot	burden	that	produces	such	symptoms	is	also	responsible	for	the	effect	on	resistance	 in	 the	 pulmonary	 circulation.	 In	 turn,	 increased	 right	 sided	 pressures	along	 with	 supply/demand	 mismatch	 likely	 has	 a	 correlating	 effect	 on	 the	conduction	system.	This	combination	of	factors	would	explain	the	correlation	of	PE	and	RHS	with	the	ECG	and	echo	findings.	While	this	may	not	be	diagnostically	useful,	it	 helps	 illustrate	 the	 pathophysiology	 of	 PE,	 and	 the	 associated	 effects	 on	hemodynamics	and	cardiac	conduction	and	contractility,	in	particular	with	the	right	ventricle.		The	findings	surrounding	prognosis	of	PE	positive	patients	with	regard	to	the	level	 of	 care	 required	 also	 seems	 to	 correlate	 with	 the	 degree	 to	 which	 the	 clot	affected	 RV	 function	 as	 determined	 by	 TAPSE	 or	 ECG	 scores.	 Patients	 requiring	“elevated	 care”	 had	 significantly	 lower	 TAPSE	 and	 significantly	 higher	 TwiST.	 In	addition,	patients	with	low	TAPSE	and	TwiST	≥5	had	significantly	increased	relative	risk	of	requiring	“elevated	care.”	Physiologically,	this	makes	sense,	as	these	patients	have	 evidence	 of	 increased	 hemodynamic	 compromise,	 and	 it	 has	 already	 been	shown	that	RV	dysfunction	 in	PE	predicts	 in-hospital	mortality	(55).	This	suggests	
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that	 those	 two	 point-of-care	 tests	 have	 prognostic	 value	 in	 PE	 care.	 However,	patient	 disposition	 may	 be	 subjective,	 and	 hospital	 length	 of	 stays	 often	 include	complications	 unrelated	 to	 the	 admitting	 diagnosis.	 One	 of	 the	 limitations	 of	 this	study	is	that	more	information	was	not	gathered	regarding	the	hospital	course	of	PE	positive	patients.	Additionally,	there	was	no	follow	up	done	with	regard	to	long	term	sequelae	 or	 morbidity/mortality	 and	 any	 association	 with	 lower	 TAPSE	 or	 high	Daniels	 or	 TwiST	 scores	 on	 initial	 presentation.	 These	 limitations	 certainly	 have	implications	 regarding	 the	 findings	 of	 this	 study	 and	 their	 internal	 validity.	 We	cannot	 say	with	 certainty	 that	 all	 cases	of	patients	 requiring	 longer	hospital	 stays	were	directly	related	to	acute	pulmonary	embolism.	Additionally,	though	we	may	be	able	 to	 comment	 on	 the	 short	 term	 prognosis	 and	 level	 of	 care	 regarding	 these	patients,	without	long	term	follow	up,	we	cannot	comment	on	how	risk	stratification	and	treatment	may	affect	long	term	morbidity	and	mortality.			In	 conclusion,	 the	 results	 of	 this	 study	 demonstrate	 a	 link	 between	 TAPSE	and	ECG	scores	as	determined	by	the	Daniels	and	TwiST	criteria,	with	RHS	being	the	likely	 common	 denominator.	 Though	 this	 may	 seem	 inherent	 based	 on	 previous	research,	this	still	may	provide	utility.	Hospital	resources	often	differ,	and	TAPSE	is	not	 a	 measurement	 that	 is	 often	 taken	 during	 bedside	 echo	 in	 emergency	departments.	 Having	 an	 understanding	 that	 there	 is	 a	 correlation	 between	 ECG	scoring	and	TAPSE	values	will	allow	practitioners	to	potentially	use	either,	or	both,	in	evaluating	a	patient	with	suspected	PE.	Additionally,	 there	was	correlation	with	the	level	of	care	required,	again	with	RHS/RV	dysfunction	being	the	likely	common	denominator.	This	 is	 consistent	with	prognostic	data	 in	prior	studies,	and	bedside	
		
40	
echo	and/or	ECG	scoring	systems	can	provide	physicians	additional	information	to	risk	 stratify	 patients	 with	 submassive	 PE	 who	 may	 require	 a	 higher	 level	 of	inpatient	care.	Of	course,	this	particular	study	was	limited	by	many	factors,	notably	the	small	sample	and	small	number	of	PE	positive	patients,	as	well	as	the	fact	that	it	was	a	convenience	sample	as	opposed	to	consecutive	enrollment,	which	may	have	affected	 the	 study’s	 internal	 validity.	 Additionally,	 limited	 data	was	 acquired	with	regard	to	patients	after	their	admission	to	the	hospital.	Further	research	would	be	helpful	in	further	determining	the	role	of	using	TAPSE	and/or	the	Daniels	or	TwiST	score	 in	 diagnosing	 and	 prognosticating	 patients	 with	 acute	 PE.	 Thus	 far	 these	modalities	 have	 shown	 to	 correlate	 well	 with	 RHS,	 and	 suggest	 to	 have	 utility	 in	diagnosing	PE	in	a	symptomatic	patient	in	which	PE	is	suspected,	but	comfirmatory	studies	 with	 larger	 sample	 sizes	 would	 provide	 more	 optimal	 cutoff	 ranges	 in	adding	to	the	current	tools	for	PE	diagnosis	and	prognosis.	
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6.	Figures	Figure	1:	TAPSE	measurement	using	M-mode	over	the	tricuspid	annulus.		
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Figure	2:	12-lead	ECG	tracing	of	a	PE	positive	patient	with	a	Daniels	score	of	20	and	TwiST	score	of	10.	(Daniels:	tachycardia	(2),	 incomplete	RBBB	(2),	TWI	V1-V4	(4),	TWI	in	V1	>2mm	(2),	TWI	in	V2	>2	mm	(3),	TWI	in	V3	>2mm	(3),	Q	III	(1),	TWI	III	(1),	SIQIIITIII	(2))	(TwiST:	TWI	V1-V3	(5),	SI	(2),	tachycardia	(3))	
	
7.	Tables	Table	1:	Demographics,	dispositions	and	length	of	stays	for	enrolled	patients.		 All	Subjects	(n=110)	 PE	+	(n=23)	 PE-	(n=87)	Age	(±SD)	 58.6	(±17.4)	 63.4	(±15.1)	 57.4	(±17.9)	Male	(%)	 45	(41)	 13	(56.5)	 32	(36.8)	Female	(%)	 65	(59)	 10	(43.5)	 55	(63.2)	Discharged	(%)	 23	(21)	 1	(4.3)	 22	(25.2)	Admit	to	Floor	(%)	 30	(27)	 13	(56.5)	 27	(31)	Admit	to	SDU/ICU	 24	(21.8)	 9	(39.1)	 15	(17)	Length	of	Stay	(±SD)	 3.9	(5.4)	 6.7	(6)	 3.3	(5.1)	
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Table	2:	Diagnostic	characteristics	of	Daniels	scores	in	diagnosing	PE.	Daniels	Score	 N(%)	 Sensitivity,	%		(95%	CI)	
Specificity,	%		(95%	CI)	
Positive	Likelihood	 Negative	Likelihood	 PPV,	%	(95%	CI)	 NPV,	%	(95%	CI)	
≤	2	PE-	 59	(56)	 58	(46-58)	 50	(28-72)	 1.2		(0.7-1.95)	 0.87		(0.55-1.37)	 83		(71-91)	 22		(11-37)	≥3	 46	(44)	 50	(28-72)	 58	(46-68)	 1.2	(0.7-1.95)	 0.87		(0.55-1.37)	 22		(11-37)	 83		(71-91)	≥7	 17	(16)	 40	(20-64)	 89	(80-95)	 3.8		(1.7-8.6)	 0.67		(0.47-0.96)	 47		(24-71)	 86		(77-92)	≥10	 12	(11)	 33	(15-57)	 94	(78-98)	 5.6	(2-16)	 0.7		(0.5-1)	 58		(23-85)	 85		(76-92)	≥12	 6	(6)	 24	(8-50)	 98		(91-100)	 10.4		(2-52)	 0.78		(0.6-1.0)	 67		(24-94)	 87		(78-93)	≥17	 3	(3)	 13	(2-42)	 99		(93-100)	 12		(1.2-124)	 0.88		(0.72-1.1)	 67		(13-98)	 87		(79-93)										
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Table	3:	Diagnostic	characteristics	of	TwiST	scores	in	diagnosing	PE.	TwiST	Score	 N(%)	 Sensitivity,	%		(95%	CI)	
Specificity,	%		(95%	CI)	
Positive	Likelihood	 Negative	Likelihood	 PPV,	%	(95%	CI)	 NPV,	%	(95%	CI)	
≤	2	PE-	 64	(61)	 63	(52-73)	 50	(27-73)	 1.4		(0.8-2.3)	 0.79		(0.49-1.3)	 86		(74-93)	 22		(11-38)	≥3	 41	(39)	 50	(27-73)	 63	(52-73)	 1.4	(0.8-2.3)	 0.79		(0.49-1.3)	 22		(11-38)	 86		(74-93)	≥5	 20	(19)	 43	(23-66)	 87	(78-93)	 3.3	(1.6-6.9)	 0.66	(0.45-1)	 45		(23-68)	 86		(77-92)	≥7	 15	(14)	 33	(15-57)	 90	(82-96)	 3.5		(1.4-8.6)	 0.74		(0.54-1.0)	 47		(22-73)	 84		(75-91)	≥8	 12	(11)	 29	(12-52)	 93	(85-97)	 4		(1.4-11)	 0.77		(0.59-1.0)	 50		(22-78)	 84		(74-90)	
	Table	4:	Diagnostic	characteristics	of	TAPSE	values	in	diagnosing	PE.	TAPSE	(mm)	 N(%)	 Sensitivity,	%		(95%	CI)	
Specificity,	%		(95%	CI)	
Positive	Likelihood	 Negative	Likelihood	 PPV,	%	(95%	CI)	
NPV,	%		(95%	CI)	
TAPSE	(17)	 24	(22)	 57	(34-77)	 87	(78-93)	 4.3		(2.2-8.3)	 0.5		(0.3-0.8)	 54		(33-74)	 88		(79-94)	TAPSE	(21)	 47	(44)	 79	(57-92)	 67	(55-76)	 2.4		(1.6-3.4)	 0.31		(0.14-0.69)	 40		(27-56)	 92		(81-97)							
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Table	5:	Diagnostic	characteristics	of	Daniels	scores	in	diagnosing	right	heart	strain			as	determined	by	“low	TAPSE.”		Daniels	Score	 N(%)	 Sensitivity%		(95%	CI)	
Specificity,	%	(95%	CI)	
Positive	Likelihood	 Negative	Likelihood	 PPV,	%		(95%	CI)	 NPV,	%	(95%	CI)	
≤	2	high	TAPSE	
53	(52)	 60	(48-71)	 77	(55-92)	 2.64		(1.2-5.8)	 0.5		(0.4-0.7)	 91		(79-97)	 35		(22-50)	
≥3	 49	(48)	 77	(55-92)	 60	(48-71)	 2.64		(1.2-5.8)	 0.5		(0.4-0.7)	 35		(22-50)	 91		(79-97)	≥7	 16(16)	 48	(27-69)	 92	(84-97)	 6.54		(3-16)	 0.6		(0.4-0.8)	 65		(38-86)	 86		(77-92)	≥10	 	17	(17)	 45	(24-68)	 96	(89-99)	 12.6		(4-42)	 0.6		(0.4-0.8)	 77		(46-95)	 87		(78-93)	≥12	 6	(6)	 22	(7-44)	 99		(93-100)	 17	(2-140)	 0.8	(0.6-1)	 83		(36-100)	 81		(72-88)	≥17	 3	(3)	 13	(3-34)	 100		(95-100)	 -------------	 0.9		(0.7-1.0)	 100		(29-100)	 80		(70-87)																
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Table	6:	Diagnostic	characteristics	of	TwiST	scores	in	diagnosing	right	heart	strain			as	determined	by	“low	TAPSE.”		TwiST	Score	 N(%)	 Sensitivity,	%		(95%	CI)	
Specificity,	%		(95%	CI)	
Positive	Likelihood	 Negative	Likelihood	 PPV,	%	(95%	CI)	 NPV,	%	(95%	CI)	
≤	2	high	TAPSE	 58	(57)	 70	(68-79)	 87	(66-97)	 5.34		(2-15)	 0.35		(0.24-0.51)	 95		(86-99)	 45		(30-61)	≥3	 44	(43)	 87	(66-97)	 70	(68-79)	 5.34		(2-15)	 0.35		(0.24-0.51)	 45		(30-61)	 95		(86-99)	≥5	 25	(25)	 59	(36-79)	 85	(75-92)	 3.9		(2.1-7.37)	 0.48	(0.29-0.8)	 52		(31-72)	 88		(79-95)	≥7	 	15	(15)	 45	(24-68)	 94	(86-98)	 7.27		(3-19)	 0.58		(0.4-0.86)	 67		(38-88)	 86		(77-93)	≥8	 12	(12)	 39	(20-61)	 96	(89-99)	 10.3		(3-35)	 0.63		(0.45-0.88)	 75		(43-95)	 84		(75-91)										
		
52	
Table	7:	Differences	in	mean	ECG	scores	for	low	vs.	high	TAPSE	and	PE	positive	vs.	PE	negative	patients.		 Daniels	 TwiST	 	TAPSE	≤17	mm	Mean	(±SD)	 7.2	(±5.9)	 5.5	(±3.3)	 	TAPSE	>	7mm	Mean	(±SD)	 2.5	(±2.5)	 1.8	(±2.4)	 	Difference	(95%	CI)	 4.7	(3.1-6.4)	 3.7	(2.5-5)	 	Level	of	significance	 p<0.0001	 p<0.0001	 		 Daniels	 TwiST	 TAPSE	PE	+	Mean	(±SD)	 5.9	(±6.1)	 4.4	(±3.4)	 17	mm	(±5.0)	PE	-	Mean	(±SD)	 2.9	(±3.2)	 2.2	(±2.7)	 22	mm	(±5.3)	Difference	(95%	CI)	 3.0	(1.1-4.9)	 2.1	(0.73-3.5)	 4.6	(2.2-7.1)	Level	of	significance	 p	=	0.0024	 p	=	0.0033	 p	=	0.0003		Table	8:	Mean	TAPSE	and	ECG	scores	for	PEEC	vs.	non-PEEC	patients,	and	relative	risk	of	PEEC.		 TAPSE	 Daniels	 TwiST	PEEC	Mean	(±SD)	 15	mm	(5.1)	 8.2	(5.4)	 6.6	(3.5)	Non-PEEC	Mean	(±SD)	 19	mm	(4.2)	 3.9	(6.1)	 3.0	(2.9)	Difference	(95%	CI)	 4.1	(0-8.2)	 4.3	(-1.0	to	9.6)	 3.6	(0.64-0.65)	Level	of	significance	 p	=	0.047	 p	=	0.11	 p	=	0.020		 TAPSE	≤17	mm	 Daniels	≥10	 TwiST	≥5	Relative	Risk	of	elevated	care	 6.9	 2.0	 4.4	95%	CI	 1-46	 0.86-4.6	 1.2-16	Level	of	significance	 p	=	0.045	 p	=	0.11	 p	=	0.025		
